What every parent should know about pfas and kidney disease
Long-term PFAS exposure is associated with kidney damage, reduced kidney function, and increased kidney cancer risk. The C8 Health Project established a probable link between PFOA exposure and kidney cancer. PFAS are eliminated primarily through the kidneys, creating concentrated exposure in renal tissue that may explain the organ-specific effects.
Renee · Founder & Lead Researcher, R3
We score every product the same way and never accept brand payment. We may earn a commission from some links, which never changes a score. How we stay independent.
Quick facts
Get the research before you buy
New picks and safety research, no spam, no sponsors.
When we talk about PFAS and health, the conversation usually starts with cancer in broad terms or endocrine disruption. But the kidneys deserve their own discussion. These are the organs responsible for filtering PFAS out of your blood - and that filtration process means renal tissue sees higher PFAS concentrations than almost any other organ in the body.
The connection between PFAS and kidney harm is not theoretical. It is built on decades of data, from the C8 Health Project studying communities near DuPont's Washington Works plant, to occupational studies of PFAS manufacturing workers, to large-scale population health surveys. The picture is consistent: elevated PFAS blood levels are associated with measurable kidney damage.
Here is what we know, what it means for your family, and what you can do about it.
PFAS (per- and polyfluoroalkyl substances) enter your body primarily through contaminated drinking water, food contact materials (including some air fryer and cookware coatings), food packaging, and household dust. Once absorbed, PFAS binds to proteins in the blood and circulates throughout the body.
Unlike most toxicants, PFAS are extraordinarily persistent. PFOA (perfluorooctanoic acid), one of the most studied PFAS compounds, has a biological half-life of approximately 3.5-4.5 years in humans. PFOS (perfluorooctane sulfonic acid) has a half-life of approximately 4.5-5.4 years. This means these chemicals accumulate in your body over years and decades of low-level exposure.
The kidneys are the primary route of PFAS elimination from the body. Renal clearance is slow but continuous - your kidneys are constantly filtering PFAS from blood, concentrating it in renal tubular fluid, and excreting a small fraction in urine while reabsorbing the rest. This reabsorption cycle means that kidney tissue is exposed to higher PFAS concentrations than the circulating blood level suggests.
This concentrated renal exposure is believed to be a key reason why the kidneys are a specific target organ for PFAS toxicity.
The C8 Health Project is the largest and most comprehensive study of PFAS health effects in a human population. Between 2005 and 2013, an independent science panel studied approximately 70,000 residents of the mid-Ohio River Valley who had been exposed to PFOA-contaminated drinking water from DuPont's Washington Works facility in Parkersburg, West Virginia.
The C8 Science Panel identified a probable link between PFOA exposure and kidney cancer. This finding was based on:
The C8 findings led to a landmark legal settlement and fundamentally changed the scientific understanding of PFAS health risks. The kidney cancer finding, specifically, has been replicated in subsequent studies of other PFAS-exposed populations.
In November 2023, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified PFOA as a Group 1 carcinogen (carcinogenic to humans). The IARC evaluation specifically cited kidney cancer as one of the cancer types with sufficient evidence in humans.
PFOS was classified as Group 2B (possibly carcinogenic to humans), with more limited evidence for kidney cancer specifically but consistent animal data.
This IARC classification is significant because Group 1 is the highest confidence level - it means the expert panel concluded that the evidence is sufficient to establish that PFOA causes cancer in humans, with kidney cancer as a specific site.
The kidney cancer data gets the headlines, but the more common kidney effects from PFAS exposure are subclinical - changes in kidney function markers that indicate damage before full disease develops.
Several large population studies have found associations between higher PFAS blood levels and lower estimated glomerular filtration rate (eGFR), the standard clinical measure of kidney function. A 2019 study using NHANES data found that each doubling of serum PFOA concentration was associated with a statistically significant decrease in eGFR. Similar findings have been reported for PFOS.
Reduced eGFR is a marker for chronic kidney disease (CKD). While the PFAS-associated reductions are typically modest at population-average exposure levels, they move in the direction of clinical CKD and are concerning for populations with already-compromised kidney function.
Multiple studies have found positive associations between PFAS blood levels and serum uric acid concentrations. Elevated uric acid is a risk factor for kidney stones, gout, and chronic kidney disease progression. The PFAS-uric acid connection has been observed in both adult and adolescent populations in NHANES data, suggesting the effect begins early in life.
Some studies have reported associations between PFAS exposure and increased urinary albumin excretion (albuminuria), an early marker of kidney damage. Albumin leaking into urine indicates that the kidney's filtration barrier is compromised. This finding has been less consistent across studies than eGFR changes but adds to the overall picture of renal harm.
Children's kidneys are developing and may be more susceptible to PFAS-mediated damage for several reasons:
Higher relative exposure. Children have lower body weight, so the same absolute PFAS intake produces higher blood concentrations. Breastfeeding is a significant transfer pathway - PFAS passes efficiently into breast milk, and exclusively breastfed infants can accumulate substantial PFAS levels in the first months of life.
Developing renal function. The kidneys continue maturing through childhood. Glomerular filtration rate does not reach adult levels until approximately age 2. Renal tubular function continues developing through adolescence. PFAS exposure during these developmental windows may have effects that differ from adult exposure.
Longer accumulation horizon. PFAS bioaccumulates over a lifetime. A child born today with PFAS in cord blood starts accumulating from day one and will carry that cumulative burden for decades. The longer the exposure duration, the higher the cumulative renal tissue dose.
The National Kidney Foundation has acknowledged PFAS as an emerging concern for kidney health, though formal clinical guidance for PFAS-related kidney screening has not yet been established.
Not all PFAS exposure pathways contribute equally to kidney burden. For families, the highest-impact reduction targets are:
Contaminated drinking water is the single largest PFAS exposure source for affected communities. In April 2024, the EPA finalized the first-ever national drinking water standards for PFAS, setting maximum contaminant levels (MCLs) of 4 parts per trillion for PFOA and PFOS individually. Water utilities serving communities near PFAS manufacturing sites, military bases with AFFF firefighting foam use, and industrial facilities have the highest contamination risk.
A quality water filter is the most direct intervention. Reverse osmosis systems remove PFAS at 90-99% efficiency. NSF/ANSI 53-certified activated carbon filters reduce PFAS by varying amounts depending on the specific compounds and filter quality.
Nonstick coatings made with PTFE (Teflon) are manufactured using PFAS processing aids. While most modern PTFE cookware claims to be PFOA-free (the specific processing aid has been phased out), replacement PFAS compounds (GenX and others) are used instead. The contribution of cookware-derived PFAS to total body burden is generally lower than drinking water but adds to cumulative exposure, especially with daily use of multiple nonstick items.
Air fryers with PTFE-coated baskets contribute to this pathway. Stainless steel or ceramic-coated baskets eliminate the nonstick coating exposure route entirely.
Grease-resistant food packaging (microwave popcorn bags, fast food wrappers, pizza boxes) has historically used PFAS-based coatings. FDA has been phasing these out, and several major food service companies have committed to PFAS-free packaging, but the transition is incomplete.
Because PFAS bioaccumulates over years, reducing exposure is a long-term strategy, not a quick fix. But every source you eliminate stops adding to the cumulative burden.
Filter your drinking water. This is the highest-impact single action for most families. Reverse osmosis is the gold standard for PFAS removal. If RO is not feasible, an NSF/ANSI 53-certified carbon block filter provides meaningful reduction. Check your water utility's PFAS testing results at the EPA's PFAS analytic tools portal.
Choose PFAS-free cookware and air fryer baskets. Stainless steel, cast iron, and ceramic-coated options eliminate the nonstick PFAS exposure pathway. For air fryers, stainless steel baskets are available from several manufacturers.
Reduce processed and fast food consumption. Food packaging PFAS transfers to food, particularly hot and greasy foods. Cooking at home with PFAS-free equipment reduces this pathway.
Support kidney health broadly. Adequate hydration, moderate sodium intake, maintaining healthy blood pressure, and regular physical activity all support kidney function and may improve the body's capacity to manage PFAS filtration. These are not PFAS-specific interventions but general kidney health measures that become more important when a toxicant burden is present.
Get your water tested. If you live near a military base, airport with firefighting foam use, or industrial facility, consider testing your well or tap water for PFAS. Several certified laboratories offer residential PFAS water testing for $200-400.
PTFE-coated air fryer baskets are one exposure source among many for PFAS. Switching to a stainless steel or ceramic-coated basket eliminates that specific pathway. But for kidney protection, filtering your drinking water is likely a higher-impact action - contaminated water delivers orders of magnitude more PFAS than cookware leaching. A reverse osmosis system or NSF/ANSI 53-certified water filter should be the first investment if kidney health from PFAS is your concern.
Kidney cancer: IARC classified PFOA as Group 1 carcinogenic to humans in 2023, with kidney cancer as a specific site with sufficient evidence. The C8 Health Project established a probable link between PFOA exposure and kidney cancer in community-level data.
Reduced kidney function: Population studies using NHANES data show associations between higher PFAS blood levels and lower estimated glomerular filtration rate (eGFR), a standard marker for chronic kidney disease.
Uric acid elevation: Multiple studies link PFAS to higher serum uric acid, a risk factor for kidney stones, gout, and CKD progression. Observed in both adults and adolescents.
Concentrated renal exposure: Kidneys filter and partially reabsorb PFAS during elimination, exposing renal tissue to higher PFAS concentrations than circulating blood levels indicate.
Bioaccumulation: PFOA has a 3.5-4.5 year half-life in humans. Cumulative lifetime exposure determines renal tissue dose, making early and sustained exposure reduction important.
IARC (WHO): PFOA classified Group 1 carcinogenic to humans (November 2023), citing kidney cancer as a specific site with sufficient evidence. PFOS classified Group 2B (possibly carcinogenic).
US EPA: Finalized first national PFAS drinking water standards in April 2024 - 4 parts per trillion MCL for PFOA and PFOS individually. Previously no enforceable federal drinking water limits existed.
C8 Science Panel: Established probable link between PFOA exposure and kidney cancer (2012), based on the largest PFAS health study ever conducted (approximately 70,000 participants).
National Kidney Foundation: Acknowledges PFAS as an emerging concern for kidney health but has not yet issued formal clinical screening guidance.
Stockholm Convention: PFOS added to the global persistent organic pollutants list in 2009. PFOA added in 2019. These international agreements aim to eliminate production and use of these specific PFAS compounds.
Who is most at risk
When to seek medical attention
Discuss PFAS exposure with your doctor if you live in a community with known PFAS water contamination, if you have worked in PFAS manufacturing or firefighting with AFFF foam, or if you have unexplained declining kidney function on routine blood work. Request serum PFAS testing if you have reason to believe you have had significant exposure. If you have pre-existing chronic kidney disease, discuss PFAS as a potential contributing factor with your nephrologist. There are no established clinical guidelines specifically for PFAS-related kidney screening in the general population, but awareness is growing among kidney specialists.
Look for these
Watch out for
What this does NOT cover
PFAS effects on other organ systems (liver, thyroid, immune system) - covered in separate terms Kidney disease from other causes (diabetes, hypertension, genetic conditions) PFAS remediation in contaminated water systems (an environmental engineering topic) Clinical management of PFAS-associated kidney cancer (consult an oncologist) PFAS exposure from non-kitchen sources like cosmetics, textiles, and firefighting foam
How to verify
Test your drinking water for PFAS through a certified laboratory (approximately $200-400 for residential testing). Check your water utility's PFAS testing results at the EPA's PFAS analytic tools portal. For personal exposure, some healthcare providers can order serum PFAS testing, though clinical interpretation guidance is still evolving. Verify water filter PFAS certification at nsf.org.
PFOA (perfluorooctanoic acid)
IARC Group 1 carcinogen. Probable link to kidney cancer (C8 study). Half-life 3.5-4.5 years. Phased out of manufacturing but persistent in environment and bodies.
PFOS (perfluorooctane sulfonic acid)
IARC Group 2B. Longer half-life (4.5-5.4 years). Associated with reduced eGFR in population studies. Similar renal concentration mechanism as PFOA.
GenX (replacement PFAS)
Shorter half-life than PFOA but still persistent. Less studied for kidney-specific effects. Used as PFOA replacement in manufacturing, including some cookware coatings.
Short-chain PFAS
Shorter half-lives and lower bioaccumulation potential. Less data on kidney effects. Some evidence of renal excretion at higher rates, potentially reducing renal tissue concentration.
What this means for your family
Every product scored on safety, efficacy, and usability - so you know which products to trust around pfas and kidney disease.
Get the Air Fryer shortlist, free
The picks that cleared safety, what to skip, and why price didn’t predict the winner.
No spam. Unsubscribe any time.
PTFE-coated air fryer baskets can contribute to total PFAS body burden, and PFAS is associated with kidney damage. However, cookware is typically a smaller PFAS source than contaminated drinking water or food packaging. The kidney effects documented in the C8 Health Project were in populations with much higher exposure from contaminated water supplies. Switching to a stainless steel basket eliminates the cookware pathway, and filtering drinking water addresses the larger source.
Kidney cancer from PFAS is most clearly documented in highly exposed populations - workers in PFAS manufacturing and communities with contaminated water supplies. The general population faces a much lower individual risk from typical environmental exposure. IARC classified PFOA as Group 1 carcinogenic with kidney as a specific cancer site, confirming the hazard is real, but absolute risk depends heavily on exposure level and duration.
Yes, if it is the right type. Reverse osmosis systems remove PFAS at 90-99% efficiency and are the most effective option. NSF/ANSI 53-certified activated carbon block filters provide meaningful reduction but vary by compound and filter quality. Standard pitcher filters with granular activated carbon provide the least PFAS reduction. Check that your specific filter is certified for PFAS reduction, not just general contaminant removal.
Developing kidneys may be more susceptible to PFAS damage. Children have higher PFAS blood concentrations relative to body weight from the same exposure, their kidneys are still maturing (full function is not reached until approximately age 2), and they have decades ahead for cumulative damage to manifest. PFAS also transfers efficiently through breast milk, meaning exposure begins in infancy for breastfed children.
Check your water utility's PFAS testing results at the EPA's PFAS analytic tools portal. If you are on well water or want independent verification, certified laboratories offer residential PFAS water testing for approximately $200-400. The new EPA standards set maximum contaminant levels of 4 parts per trillion for PFOA and PFOS individually - your utility must test and report against these limits.
Some healthcare providers can order serum PFAS testing. Quest Diagnostics and other major labs offer PFAS blood panels. Clinical interpretation is still evolving - there are no established 'safe' blood level thresholds - but testing can confirm whether your exposure is above the general population median. This is most useful for people with known high-exposure pathways (contaminated water, occupational exposure).
PFOA has a biological half-life of approximately 3.5-4.5 years, and PFOS is 4.5-5.4 years. This means it takes roughly 7-10 years for your body to eliminate half of the current PFAS burden through renal and other clearance pathways. Eliminating exposure sources stops adding to the burden, but the existing accumulation declines slowly. This is why early and sustained exposure reduction matters more than acute changes.